Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression

Background: Across psychotherapeutic frameworks, the strength of the therapeutic alliance has been found to correlate with treatment outcomes; however, its role has never been formally assessed in a trial of psychedelic-assisted therapy. We aimed to investigate the relationships between therapeutic...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Frontiers in Pharmacology
المؤلفون الرئيسيون:	Roberta Murphy, Hannes Kettner, Rick Zeifman, Bruna Giribaldi, Laura Kartner, Jonny Martell, Tim Read, Ashleigh Murphy-Beiner, Michelle Baker-Jones, David Nutt, David Erritzoe, Rosalind Watts, Robin Carhart-Harris
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2022-03-01
الموضوعات:	psilocybin therapeutic alliance therapeutic relationship emotional breakthrough mystical experience depression
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fphar.2021.788155/full

مواد مشابهة

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
حسب: Julia Bornemann, وآخرون
منشور في: (2024-06-01)

Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies
حسب: William Roseby, وآخرون
منشور في: (2025-06-01)

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
حسب: Sara de la Salle, وآخرون
منشور في: (2024-07-01)

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat
حسب: Grace Blest-Hopley, وآخرون
منشور في: (2025-08-01)

Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
حسب: Luca Pellegrini, وآخرون
منشور في: (2025-10-01)

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
حسب: Tommaso Barba, وآخرون
منشور في: (2022-09-01)

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
حسب: Richard J. Zeifman, وآخرون
منشور في: (2023-08-01)

Pharmacokinetics of Psilocybin: A Systematic Review
حسب: Shakila Meshkat, وآخرون
منشور في: (2025-03-01)

Effects of DMT on mental health outcomes in healthy volunteers
حسب: Christopher Timmermann, وآخرون
منشور في: (2024-02-01)

Psilocybin as a new way for depression treatment
حسب: Mateusz Maciej Pawlicki, وآخرون
منشور في: (2024-05-01)

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings
حسب: Megan Calnan, وآخرون
منشور في: (2025-07-01)

The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin
حسب: Tobias P. Whelan, وآخرون
منشور في: (2024-04-01)

Psychotherapy with Psilocybin for Depression: Systematic Review
حسب: Jonathan Joseph Dawood Hristova, وآخرون
منشور في: (2023-03-01)

Electrical spiking of psilocybin fungi
حسب: Antoni Gandia, وآخرون
منشور في: (2022-12-01)

ARC: a framework for access, reciprocity and conduct in psychedelic therapies
حسب: Meg J. Spriggs, وآخرون
منشور في: (2023-05-01)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
حسب: Balázs Szigeti, وآخرون
منشور في: (2023-07-01)

Neuroprotective effects of psilocybin in a rat model of stroke
حسب: Seong-Jin Yu, وآخرون
منشور في: (2024-10-01)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
حسب: K. Shah, وآخرون
منشور في: (2022-06-01)

Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
حسب: Jacob S. Aday, وآخرون
منشور في: (2025-03-01)

Psilocybin's Emerging Role in Combating Depressive Disorder
حسب: Anna Jaremek, وآخرون
منشور في: (2023-08-01)

The Therapeutic Potential of Psilocybin
حسب: Henry Lowe, وآخرون
منشور في: (2021-05-01)

Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters
حسب: Jonathan Cohen, وآخرون
منشور في: (2025-04-01)

Exploring the role of the psychedelic alkaloid psilocybin in alleviating cancer-related distress
حسب: Fejzić Dino
منشور في: (2025-03-01)

Rediscovering Psilocybin as an Antidepressive Treatment Strategy
حسب: Rene Zeiss, وآخرون
منشور في: (2021-09-01)

Effects of psilocybin-assisted therapy on treatment-resistant depression
حسب: A. Fraga, وآخرون
منشور في: (2021-04-01)

Psilocybin-assisted therapy and HIV-related shame
حسب: Nicky J. Mehtani, وآخرون
منشور في: (2024-08-01)

Psilocybin and Mental Health–Don't Lose Control
حسب: Joseph M. Barnby, وآخرون
منشور في: (2018-07-01)

Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals
حسب: Erin Wang, وآخرون
منشور في: (2024-11-01)

Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
حسب: Sandra Szafoni, وآخرون
منشور في: (2024-06-01)

The Emergence of Psilocybin in Psychiatry and Neuroscience
حسب: Hossein Omidian, وآخرون
منشور في: (2025-04-01)

Psychedelics and sexual functioning: a mixed-methods study
حسب: Tommaso Barba, وآخرون
منشور في: (2024-02-01)

The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice
حسب: Timur Zanikov, وآخرون
منشور في: (2023-03-01)

Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests
حسب: Grant Jones, وآخرون
منشور في: (2023-08-01)

LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice
حسب: Gregory Ian Robinson, وآخرون
منشور في: (2025-03-01)

Refractory CRPS pain treated with psilocybin: A case report
حسب: David S. Jevotovsky, وآخرون
منشور في: (2024-09-01)

Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension
حسب: Grant M. Jones, وآخرون
منشور في: (2024-06-01)

Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
حسب: N. Descalço, وآخرون
منشور في: (2021-04-01)

Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
حسب: Maurizio Coppola, وآخرون
منشور في: (2022-02-01)

Is there mush-room to improve the environmental sustainability of psilocybin production?
حسب: Luke Lanham, وآخرون
منشور في: (2025-08-01)

A narrative exploration of psilocybin’s potential in mental health
حسب: Huitae Min, وآخرون
منشور في: (2024-10-01)